ExLibris header image
SFX Logo
Title: Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
Source:

Frontiers in Genetics [1664-8021] Tong, Yin yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Alonso Dominguez, Juan M. "PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase." American journal of hematology 90.1 (2015): 20-6. Link to Full Text for this item Link to SFX for this item
2. Alikian, M. "Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients." The journal of molecular diagnostics 18.2 (2016): 176-189. Link to SFX for this item
3. Conti, Rena M. "Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU." Annals of hematology 94.2 (2015): 249-257. Link to Full Text for this item Link to SFX for this item
4. Bunting, Kevin D. "Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis." PLoS ONE 10.2 (2015). Link to Full Text for this item Link to SFX for this item
5. Etienne, G. "ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?" American journal of hematology (2015): 37-41. Link to Full Text for this item Link to SFX for this item
6. Van Etten, Carl A. "Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1." Blood 127.14 (2016): 1803-1813. Link to SFX for this item
7. Jackson, Jennifer B. "Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR." The journal of molecular diagnostics 18.2 (2016): 235-243. Link to SFX for this item
8. Bennour, A. "Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays." Critical reviews in oncology/hematology 97.C (2015): 263-274. Link to SFX for this item
9. Darkow, T. "Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs." PharmacoEconomics 25.6 (2007): 481-496. Link to SFX for this item
10. Shih, Ya-Chen T. "Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011." Journal of clinical oncology 33.19 (2015): 2190-6. Link to SFX for this item
11. Simonsson, B. "Epidemiology of chronic myeloid leukaemia: an update." Annals of hematology 94.2 (2015): 241-247. Link to Full Text for this item Link to SFX for this item
12. Muendlein, A. "Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease." American journal of hematology 90.1 (2014): -21. Link to Full Text for this item Link to SFX for this item
13. O'Brien, S. "The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatment." Expert review of hematology 6.5 (2013): 575-586. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.